ClinicalTrials.Veeva

Menu

The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure

M

Moy-Fincher Medical Group

Status

Unknown

Conditions

Scars

Treatments

Device: Lumenis fractional carbon dioxide laser

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine if fractional carbon dioxide laser treatment of a fresh wound at the time of surgery, decreases scar formation. Scar revision is commonly done at 6-10 weeks following surgery. Therefore, it may be more beneficial, for both the patient and physician, to perform scar revision at the time of surgery.

Enrollment

10 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Undergoing skin cancer surgery
  • Will have a straight-line incision
  • Fluent in English
  • Must reside in the Los Angeles vicinity for the duration of the study

Exclusion criteria

  • Non-English speakers
  • Pregnant or cognitively impaired subjects

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

10 participants in 2 patient groups

Control
No Intervention group
Description:
Half of each subject's wound will not be treated.
Laser resurfacing
Experimental group
Description:
Half of each subject's wound will be treated with a fractional CO2 laser.
Treatment:
Device: Lumenis fractional carbon dioxide laser

Trial contacts and locations

1

Loading...

Central trial contact

Telia DeBoyes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems